Proinflammatory actions of glucocorticoids: Glucocorticoids and TNFα coregulate gene expression in vitro and in vivo

Endocrinology

Volumn 153, Issue 8, 2012, Pages 3701-3712

  Lannan, Erica A ^a,b   Galliher Beckley, Amy J ^a,c   Scoltock, Alyson B ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Prairie State College   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; PROTEIN; SERPINA3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA SOLUBLE RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DEXAMETHASONE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; MALE; MICE; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; RECEPTORS, TUMOR NECROSIS FACTOR; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864383684     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1020     Document Type: Article

References (39)

1. Revollo JR, Cidlowski JA 2009 Mechanisms generating diversity in glucocorticoid receptor signaling. Ann NY Acad Sci 1179:167-178
2. Baschant U, Tuckermann J 2010 The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120:69-75
3. Magnussen H, Watz H 2009 Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 6:648-651
4. Ross KR, Chmiel JF, Konstan MW 2009 The role of inhaled corticosteroids in the management of cystic fibrosis. Paediatr Drugs 11:101-113
5. Lane NE, Yao W 2010 Glucocorticoid-induced bone fragility. Ann NY Acad Sci 1192:81-83
6. Brown ES 2009 Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann NY Acad Sci 1179:41-55
7. Gonzalez AV, Li G, Suissa S, Ernst P 2010 Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther 23:65-70
8. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F 2009 Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119-1124
9. McDonough AK, Curtis JR, Saag KG 2008 The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20:131-137 (Pubitemid 351339883)
10. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA 2004 Glucocorticoids and tumor necrosis factor α cooperatively regulate tolllike receptor 2 gene expression. Mol Cell Biol 24:4743-4756 (Pubitemid 38668041)
11. Webster JC, Huber RM, Hanson RL, Collier PM, Haws TF, Mills JK, Burn TC, Allegretto EA 2002 Dexamethasone and tumor necrosis factor-α act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology 143:3866-3874 (Pubitemid 35244366)
12. Ishii T, Matsuse T, Teramoto S, Matsui H, Hosoi T, Fukuchi Y, Ouchi Y 2000 Association between α-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Invest 30:543-548 (Pubitemid 30330469)
13. Sandford AJ, Chagani T, Weir TD, Paré PD 1998 α1- antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers 13:257-260 (Pubitemid 28115990)
14. Baker C, Belbin O, Kalsheker N, Morgan K 2007 SERPINA3 (aka α-1-antichymotrypsin). Front Biosci 12:2821-2835
15. Cichy J, Potempa J, Chawla RK, Travis J 1995 Stimulatory effect of inflammatory cytokines on α1-antichymotrypsin expression in human lung-derived epithelial cells. J Clin Invest 95:2729-2733
16. Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R, Bar-Even A, Horn-Saban S, Safran M, Domany E, Lancet D, Shmueli O 2005 Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21:650-659 (Pubitemid 40424791)
17. Wang YC, Liu HC, Liu TY, Hong CJ, Tsai SJ 2001 Genetic association analysis of α-1-antichymotrypsin polymorphism in Parkinson's disease. Eur Neurol 45:254-256
18. Lin JJ, Yueh KC, Chang CY, Chen CH, Lin SZ 2004 The homozygote AA genotype of the α1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women. Parkinsonism Relat Disord 10:469-473
19. Matsubara E, Amari M, Shoji M, Harigaya Y, Yamaguchi H, Okamoto K, Hirai S 1989 Serum concentration of α1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type. Prog Clin Biol Res 317:707-714
20. Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Harigaya Y, Wakabayashi K 1990 α1-Antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 28:561-567 (Pubitemid 20359164)
21. Abraham CR 2001 Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease. Neurobiol Aging 22:931-936 (Pubitemid 34066561)
22. Muñoz E, Obach V, Oliva R, Martí MJ, Ezquerra M, Pastor P, Ballesta F, Tolosa E 1999 α1-Antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease. Neurology 52:297-301 (Pubitemid 29059055)
23. Wang J, Zhao CY, Si YM, Liu ZL, Chen B, Yu L 2002 ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset. Mov Disord 17:767-771 (Pubitemid 41295022)
24. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D 2002 Genetic study of apolipoprotein E gene, α-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446-449 (Pubitemid 34525244)
25. O'Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, Carter DC 1995 Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 269:E323-E330
26. Machein U, Lieb K, Hüll M, Fiebich BL 1995 IL-1β and TNFα, but not IL-6, induce α1-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport 6:2283-2286
27. Cidlowski JA, Bellingham DL, Powell-Oliver FE, Lubahn DB, Sar M 1990 Novel antipeptide antibodies to the human glucocorticoid receptor: recognition of multiple receptor forms in vitro and distinct localization of cytoplasmic and nuclear receptors. Mol Endocrinol 4:1427-1437 (Pubitemid 20356602)
28. Gross KL, Oakley RH, Scoltock AB, Jewell CM, Cidlowski JA 2011 Glucocorticoid receptor α isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol Endocrinol 25:1087-1099
29. Galliher-Beckley AJ, Williams JG, Cidlowski JA 2011 Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 31:4663-4675
30. Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ, Archer TK 2000 Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem 275:17771-17777 (Pubitemid 30430827)
31. Lu NZ, Cidlowski JA 2005 Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:331-342 (Pubitemid 41350538)
32. Kalsheker N, Morley S, Morgan K 2002 Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsin. Biochem Soc Trans 30:93-98
33. Kumar R, Volk DE, Li J, Lee JC, Gorenstein DG, Thompson EB 2004 TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci USA 101:16425-16430 (Pubitemid 39557729)
34. Langlais D, Couture C, Balsalobre A, Drouin J 2008 Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response. PLoS Genet 4:e1000224
35. Barnes PJ 1998 Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 94:557-572 (Pubitemid 28269054)
36. Liberman AC, Druker J, Perone MJ, Arzt E 2007 Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev 18:45-56 (Pubitemid 46420547)
37. Bergann T, Zeissig S, Fromm A, Richter JF, Fromm M, Schulzke JD 2009 Glucocorticoids and tumor necrosis factor-α synergize to induce absorption by the epithelial sodium channel in the colon. Gastroenterology 136:933-942
38. Kasza A, Bugno M, Koj A 1994 Long-term culture of HepG2 hepatoma cells as a model for liver acute phase response during chronic inflammation. Effects of interleukin-6, dexamethasone and retinoic acid. Biol Chem Hoppe Seyler 375:779-783
39. Adcock IM, Caramori G 2001 Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79:376-384 (Pubitemid 32744283)